Phase I study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: expression analysis of genes related to outcome. (Record no. 15937345)

MARC details
000 -LEADER
fixed length control field 02336 a2200577 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515010021.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200602s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0732-183X
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1200/JCO.2005.02.0628
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Saif, M Wasif
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20060213
245 00 - TITLE STATEMENT
Title Phase I study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: expression analysis of genes related to outcome.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Date of publication, distribution, etc. Dec 2005
300 ## - PHYSICAL DESCRIPTION
Extent 8679-87 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase I; Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adenocarcinoma
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antimetabolites, Antineoplastic
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Capecitabine
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Combined Modality Therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Deoxycytidine
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dihydrouracil Dehydrogenase (NADP)
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dose-Response Relationship, Drug
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dose-Response Relationship, Radiation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Fluorouracil
General subdivision analogs & derivatives
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Gene Expression Regulation, Neoplastic
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hematologic Diseases
General subdivision etiology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pancreatic Neoplasms
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Radiotherapy, Adjuvant
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Statistics as Topic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Survival Analysis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thymidine Phosphorylase
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tumor Necrosis Factor-alpha
General subdivision genetics
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Eloubeidi, Mohammaed A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Russo, Suzanne
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Steg, Adam
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Thornton, Jennifer
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fiveash, John
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Carpenter, Mark
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Blanquicett, Carmello
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Diasio, Robert B
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Johnson, Martin R
773 0# - HOST ITEM ENTRY
Title Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Related parts vol. 23
-- no. 34
-- p. 8679-87
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1200/JCO.2005.02.0628">https://doi.org/10.1200/JCO.2005.02.0628</a>
Public note Available from publisher's website

No items available.